Profil
Said Saim formerly worked at Collegium Pharmaceutical, Inc., as Senior Director-Pharmaceutical Development from 2008 to 2013, Boehringer Ingelheim Pharmaceuticals, Inc., as Principal Scientist, Higuchi Bioscience Center, as Assistant Research Professor, and EyePoint Pharmaceuticals, Inc., as Chief Technology Officer & Senior VP from 2019 to 2024.
Dr. Saim received his graduate degree and doctorate degree from the University of Kansas.
Ehemalige bekannte Positionen von Said Saim
| Unternehmen | Position | Ende |
|---|---|---|
| EYEPOINT, INC. | Technik-/Wissenschafts-/F&E-Leiter | 01.12.2024 |
Higuchi Bioscience Center | Corporate Officer/Principal | - |
Boehringer Ingelheim Pharmaceuticals, Inc.
Boehringer Ingelheim Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceuticals products | Corporate Officer/Principal | - |
| COLLEGIUM PHARMACEUTICAL, INC. | Corporate Officer/Principal | - |
Ausbildung von Said Saim
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 5 |
|---|---|
Collegium Pharmaceutical, Inc.
Collegium Pharmaceutical, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures pharmaceutical products | Health Technology |
EyePoint Pharmaceuticals, Inc.
EyePoint Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and markets ophthalmic pharmaceuticals | Health Technology |
University of Kansas
University of Kansas Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Boehringer Ingelheim Pharmaceuticals, Inc.
Boehringer Ingelheim Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceuticals products | Health Technology |
Higuchi Bioscience Center |
















